Research
Should AMD be classified as a panretinal disease?
Investigators utilize three imaging modalities to quantify peripheral retinal abnormalities over a five-year period.
Pipeline
Samsara Vision reports 6-month postop data on SING IMT for AMD
Improved distance and near vision noted following prosthetic device implantation, with near distance reading ability increasing nearly 70%.
Business
WAVE Eye Care launches as new specialty contact lens division
EyePrint Prosthetics, Advanced Vision Technologies, and WAVE Contact Lens System join forces to offer unique and customized specialty contact lens offerings.
Research
Real-world data confirms long-term efficacy of OMNI Surgical System for POAG
Sight Sciences announces 36-month findings demonstrating continued effectiveness of standalone OMNI surgery with either IOP or medication reductions over time.
Legal
New OCTA CPT code goes into effect
Effective Jan. 1, ECPs now have a new billing code for reporting computerized ophthalmic diagnostic imaging of the retina.
Events
Los Angeles County Optometric Society calls for donations to help wildfire victims
Amidst ongoing fires, the organization is coordinating donations of eyecare supplies and emergency care for displaced residents and first responders.
Pipeline
Tenpoint reports positive topline data from phase 3 presbyopia eye drop study
With BRIMOCHOL PF meeting its prespecified primary endpoints, the company is planning for a regulatory filing within the first half of 2025.
Business
Bausch + Lomb adds to glaucoma and GA pipeline with two deals
Latest developments involve the acquisition of WhiteCap Biosciences and its GA candidate, as well as a partnership with RNAi-focused City Therapeutics.
Products
FDA accepts revised sNDA of IZERVAY for GA
Company is requesting inclusion of 24-month data to extend approved dosage for an additional 12 months for both every-month and every-other-month dosing.
Research
Too much Vitamin D may lead to AMD development
Observed association may be caused by higher sunlight exposure in this patient population.
Products
FDA approves Zeiss MEL 90 excimer laser
Integrated with the company’s Corneal Refractive Workflow, this laser system is indicated to reduce or eliminate myopia, hyperopia, and mixed astigmatism.
Business
Aviceda raises $207M to support phase 3 testing of AVD-104 for GA
Financing will support advancement of AVD-104, designed to target a specific area of the innate immune response relating to AMD.
Pipeline
FDA grants Rare Pediatric Disease Designation for ViGeneron's RP gene therapy
Designation qualifies VG901 to receive a priority review voucher if approved; company also receives dose escalation approval for phase 1 trial.
Pipeline
Acelyrin announces phase 2 data and phase 3 design for TED therapy
Clinical findings support lonigutamab as the first subcutaneous anti-IGF-1R to demonstrate robust efficacy in TED patients comparable to IV-administered standard of care.
Products
FDA clears Epithelial Thickness Module for Heidelberg's imaging platform
Exclusive to the ANTERION segment imaging platform, this module is designed to improve precision and outcomes in cornea, cataract, and refractive care.
Events
Women in Eyecare offers collaborative care for industry members
With an eye on advancing career growth and professional support, this inclusive nonprofit welcomes men and women in the eyecare industry to join.
Research
Earlier PPV may benefit vitrectomy among PDR patients
Early PPV associated with improved visual outcomes and fewer severe complications.
Events
Bausch + Lomb launches second annual glaucoma awareness campaign
As part of a partnership with the Glaucoma Research Foundation, this month-long initiative honors January as Glaucoma Awareness Month.
Research
Is there a link between peripheral neuropathy and DED risk?
Study finds association between diabetic peripheral neuropathy and risk of developing DED.
Pipeline